Flu vaccine study in kids aims to find best dosing strategy

NCT ID NCT06095947

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested a quadrivalent influenza vaccine in 652 healthy children aged 3-8 years. Researchers compared immune responses after one dose versus two doses, and also checked for side effects. The goal was to find the best way to protect children against flu.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

quadrivalent influenza vaccine (split virion, inactivated)

What this could lead to

If successful, this could help determine the best dosing schedule for flu protection in young children.

What could go wrong

This is a completed study focused on immune response and safety, not on preventing actual flu illness. Results may not apply to other age groups or flu seasons.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GCP are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Kou Zengqiang

    Jinan, Shandong, 250000, China